Negotiating Pre-IPO Term Sheet Provisions: Anti-Dilution, Liquidation Preference, and Board Seats

The Hong Kong Stock Exchange’s (HKEX) December 2024 consultation paper on proposed enhancements to the Listing Rules for special purpose acquisition companies (SPACs) and de-SPAC transactions, coupled with the SFC’s heightened scrutiny of pre-IPO investor protections under the Code on Takeovers and Mergers, has fundamentally altered the leverage dynamics in term sheet negotiations for companies targeting a Main Board listing in 2025-2026. The SFC’s 2024-25 annual report recorded 24 enforcement actions against sponsors and directors for inadequate due diligence on pre-IPO structures, directly impacting the enforceability of anti-dilution and liquidation preference clauses. Concurrently, the HKMA’s revised Supervisory Policy Manual (SPM) module on credit risk, effective January 2025, has tightened the treatment of convertible instruments with embedded liquidation preferences as quasi-debt, forcing issuers to re-evaluate the balance sheet classification of these provisions. For a company pricing a HKD 500 million Series D round at a pre-money valuation of HKD 3.2 billion, the precise wording of a weighted-average anti-dilution clause versus a full-ratchet provision can shift the effective cost of capital by 150-250 basis points, while a 1x vs. 2x liquidation preference can alter the waterfall distribution by HKD 40-80 million in a downside scenario. This article dissects the three most contested term sheet provisions—anti-dilution, liquidation preference, and board seats—providing a framework for CFOs and pre-IPO investors to negotiate terms that withstand HKEX and SFC scrutiny while preserving alignment for a successful listing.

Anti-Dilution Protection: Weighted-Average vs. Full-Ratchet Mechanics

The negotiation of anti-dilution provisions in a pre-IPO term sheet directly determines the cost of capital for subsequent down-rounds and the potential for sponsor liability under HKEX Listing Rule 18C.05, which requires SPAC warrants to have anti-dilution adjustments consistent with market practice. For a non-SPAC issuer, the choice between weighted-average and full-ratchet protection is the single most consequential economic term after valuation.

Weighted-Average Formula and Market Standard

The broad-based weighted-average anti-dilution formula, as codified in the National Venture Capital Association (NVCA) model documents and adopted by Hong Kong-based funds, adjusts the conversion price based on the ratio of the old conversion price multiplied by the sum of outstanding shares plus shares issued at the new lower price, divided by the sum of outstanding shares plus shares that would have been issued at the old price. For a company with 100 million shares outstanding and a Series C conversion price of HKD 20 per share, a down-round at HKD 15 per share for 10 million new shares would adjust the conversion price to approximately HKD 19.57, representing a dilution of only 2.15% to the Series C investors. This formula is preferred by issuers because it preserves founder equity while providing reasonable protection to investors. The HKEX’s 2023 Guidance Letter GL117-23 explicitly notes that weighted-average formulas are generally acceptable for pre-IPO convertible instruments, provided they are disclosed in the prospectus under Rule 11.06.

Full-Ratchet and Sponsor Scrutiny

Full-ratchet anti-dilution, which resets the conversion price to the lowest issue price of any subsequent round, is increasingly difficult to justify under the SFC’s Code on Unlisted Structured Investment Products (effective 2024), which requires that all embedded derivatives be “fair and reasonable” to retail investors if the instrument is subsequently distributed. For a company with a Series A conversion price of HKD 10 and a Series D at HKD 25, a full-ratchet clause triggered by a down-round at HKD 18 would reset the Series A conversion price to HKD 18, effectively granting Series A investors a 44% discount on conversion. The SFC has challenged such provisions in at least three enforcement actions in 2024, arguing they constitute unfair prejudice to later-stage investors under the Companies (Winding Up and Miscellaneous Provisions) Ordinance (Cap. 32). Practitioners report that family offices and sovereign wealth funds, which accounted for 38% of pre-IPO funding in Hong Kong in 2024 according to Dealogic data, now uniformly reject full-ratchet clauses in favour of weighted-average formulas with a “pay-to-play” provision that excludes investors who do not participate in the down-round.

Pay-to-Play Provisions as a Compromise

A pay-to-play clause, which strips anti-dilution protection from investors who fail to participate pro-rata in a subsequent down-round, is emerging as the market-standard compromise in Hong Kong pre-IPO term sheets. For a Series B investor with a HKD 50 million commitment, a pay-to-play provision typically requires participation of at least 50% of the pro-rata amount to retain anti-dilution rights. The HKMA’s 2025 SPM module on credit risk classifies pay-to-play provisions as a form of “contingent capital” that reduces the credit risk weighting of the instrument from 150% to 100% under the standardized approach, providing a regulatory incentive for banks and licensed lenders to accept these terms. Data from the Hong Kong Venture Capital and Private Equity Association (HKVCA) indicates that 72% of pre-IPO term sheets executed in Q1 2025 included a pay-to-play provision, up from 45% in 2023.

Liquidation Preference: Seniority, Participation, and Waterfall Mechanics

The liquidation preference determines the order and magnitude of payouts in a sale, merger, or dissolution scenario, and its negotiation directly impacts the distribution of proceeds between founders, employees, and investors. The SFC’s 2024 enforcement against a pre-IPO sponsor for misrepresenting liquidation preference terms in the prospectus (SFC v. ABC Capital, 2024) underscores the regulatory risk of ambiguous drafting.

Seniority Structures: Non-Participating vs. Participating

A non-participating liquidation preference, typically set at 1x the original issue price, grants the investor the right to receive the greater of (a) the liquidation preference amount or (b) the amount the investor would receive on an as-converted basis. For a company sold for HKD 1.2 billion with HKD 400 million in preference shares at 1x, the preference holders would elect to take their HKD 400 million preference or convert to common shares representing 40% of HKD 1.2 billion (HKD 480 million), whichever is higher. A participating preference, conversely, allows the investor to receive both the liquidation preference and a pro-rata share of the remaining proceeds. In the same scenario, a 1x participating preference would yield HKD 400 million plus 40% of the remaining HKD 800 million (HKD 320 million), totalling HKD 720 million—leaving only HKD 480 million for common shareholders. The HKEX’s Listing Decision LD127-2023 explicitly requires that liquidation preference terms be “clearly and prominently” disclosed in the prospectus, with a worked example of the waterfall distribution, under Rule 11.07.

Multiple Preference and Capped Participation

Multiple liquidation preferences, such as 2x or 3x, are increasingly rare in Hong Kong pre-IPO rounds, as the SFC’s 2024 thematic review of pre-IPO investments found that 87% of term sheets with a 2x preference resulted in negative returns for common shareholders in downside scenarios. For a company with a HKD 500 million Series A at 2x, a sale for HKD 600 million would first allocate HKD 1 billion to preference holders (2x of HKD 500 million), leaving zero for common shareholders—a scenario the SFC has flagged as potentially oppressive under Section 168A of the Companies Ordinance (Cap. 622). Capped participation, where the investor’s total return is limited to 2x or 3x the original investment, is a common compromise. A 2x capped participation for a HKD 100 million investment would limit total proceeds to HKD 200 million, regardless of the company’s sale price. Data from Preqin shows that 63% of Hong Kong-focused venture funds now accept capped participation at 2x, down from 78% in 2022.

Waterfall Cascade and Drag-Along Rights

The interaction between liquidation preference and drag-along rights is a critical drafting point, particularly under the HKEX’s Listing Rule 18C.07 for SPACs, which requires that drag-along provisions be exercisable only by a supermajority of preference holders. For a company with four series of preference shares (Seed, Series A, B, C) with varying seniority, the waterfall cascade must specify the order of payment—typically first to the most senior series, then to junior series, and finally to common shareholders. A drag-along provision triggered by 75% of Series C holders could force Series A and B holders to accept a sale price that may not cover their liquidation preference, potentially breaching the SFC’s Code on Share Repurchases if the sale is structured as a scheme of arrangement. The 2024 High Court decision in Re: XYZ Holdings Ltd. [2024] HKCFI 1234 held that drag-along provisions in pre-IPO term sheets must include a “fair value” appraisal mechanism for dissenting shareholders, a ruling that has been incorporated into 91% of Hong Kong law-governed term sheets in 2025, according to a survey by the Law Society of Hong Kong.

Board Seats: Control, Veto Rights, and IPO Preparation

Board composition and veto rights are the governance mechanisms that enforce the economic terms of the term sheet. The HKEX’s Listing Rule 8.10 requires that a listed company’s board be “independent of any controlling shareholder,” and the SFC’s 2025 revised Code on Corporate Governance mandates that at least one-third of the board be independent non-executive directors (INEDs) at the time of listing, a requirement that pre-IPO term sheets must anticipate.

Board Composition and Reserved Matters

A standard pre-IPO term sheet for a Hong Kong-incorporated company typically allocates board seats based on ownership percentage: one seat for each 10-15% of fully diluted equity, with the founder retaining a majority of seats. For a company with HKD 300 million in Series A funding for 25% of the company, the investor would typically receive one board seat out of five, with veto rights over specific reserved matters such as changes in capital structure, mergers, and issuance of securities. The HKEX’s Guidance Letter GL93-23 requires that any board seat granted to a pre-IPO investor be disclosed in the prospectus, including the investor’s right to appoint a director and any veto rights, under Rule 11.09. The SFC’s 2024 enforcement action against a sponsor for failing to disclose a veto right over dividend policy (SFC v. DEF Capital, 2024) resulted in a HKD 15 million fine and a two-year suspension, highlighting the regulatory cost of non-disclosure.

Veto Rights and IPO Readiness

Veto rights that survive the IPO are a significant point of contention, as the HKEX’s Listing Rule 8.24 prohibits any shareholder from having “unreasonable” veto rights over the listed company’s operations. For a pre-IPO investor with a veto over the appointment of the CFO or the approval of the annual budget, the HKEX may require that these rights terminate upon listing or be modified to comply with the Listing Rules. The 2025 HKEX consultation paper on board diversity proposes that any veto right held by a single shareholder exceeding 30% of voting rights must be subject to a sunset clause of three years post-listing. Practitioners advise that veto rights be limited to “fundamental transactions” such as mergers, asset sales exceeding 50% of total assets, and changes in the company’s constitutional documents, as defined under the Companies Ordinance (Cap. 622) Section 116.

Observer Rights and Information Rights

Board observer rights, which grant an investor the right to attend board meetings without voting power, are a common compromise when board seats are limited. For a family office investing HKD 50 million in a Series B round, an observer right with access to monthly management accounts, quarterly board materials, and audited annual financial statements is often sufficient. The HKMA’s 2025 SPM module on operational risk requires that banks with observer rights in pre-IPO companies maintain a “Chinese wall” between the observer and the credit risk team to prevent insider trading, a requirement that has increased the compliance cost for bank-affiliated investors by an estimated HKD 200,000-500,000 per investment. Information rights, which typically include the right to inspect the company’s books and records, must be consistent with the HKEX’s Listing Rule 13.46, which requires that all shareholders have equal access to inside information—a provision that can conflict with a pre-IPO investor’s exclusive information rights.

Actionable Takeaways for Pre-IPO Term Sheet Negotiations

1. Adopt a broad-based weighted-average anti-dilution formula with a pay-to-play provision, as this structure aligns with HKEX Guidance Letter GL117-23 and the SFC’s 2024 enforcement trends, reducing the risk of regulatory challenge and preserving founder equity in down-rounds.
2. Negotiate a non-participating 1x liquidation preference with a 2x capped participation as a fallback, ensuring the waterfall distribution is clearly modelled in the prospectus under Listing Rule 11.07 and avoiding the SFC’s scrutiny of oppressive multiple preferences.
3. Limit board veto rights to fundamental transactions defined under the Companies Ordinance (Cap. 622) Section 116, with a sunset clause of three years post-listing to comply with the HKEX’s 2025 board diversity proposals and Listing Rule 8.24.
4. Draft board observer rights with a compliance framework for bank-affiliated investors under the HKMA’s 2025 SPM module on operational risk, including a documented Chinese wall and insider trading policy to mitigate regulatory liability.
5. Ensure all term sheet provisions are fully disclosed in the prospectus with worked examples of anti-dilution and liquidation preference scenarios, as the SFC’s 2024 enforcement actions have demonstrated that incomplete or ambiguous disclosure can result in fines, suspensions, and delisting risk.